Specify a stock or a cryptocurrency in the search bar to get a summary
Orphazyme A/S
ORPHAOrphazyme A/S does not have significant operations. Previously, it was engaged in the development of therapies for the treatment of neurodegenerative rare diseases. The company was incorporated in 2009 and is based in Herlev, Denmark. Address: Visionhouse, Herlev, Denmark, 2730
Analytics
WallStreet Target Price
724.09 DKKP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ORPHA
Dividend Analytics ORPHA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ORPHA
Stock Valuation ORPHA
Financials ORPHA
Results | 2019 | Dynamics |